UW News

October 4, 2016

Oct. 10 bioengineering lecture focuses on accelerating drug delivery

Kinam Park

Kinam Park

After the first modern drug delivery technologies were developed in the 1950s, the next 30-year period was highly productive in producing clinically useful formulations. Yet we’ve made only limited progress in the last 30 years.

How we can accelerate growth in effectively delivering new oral and transdermal drug delivery techniques will be the focus of the University of Washington Department of Bioengineering’s 2016 Allan S. Hoffman Lecture on Oct. 10.

Kinam Park, the Showalter Distinguished Professor of Biomedical Engineering at Purdue University, will deliver the lecture titled “Drug Delivery Systems: Accelerated Evolution for the Future” at 4:30 p.m. at the Genome Sciences Auditorium in S060 Foege South, with a reception to follow.

Park, whose research focuses on using polymers and hydrogels for formulation and development of oral and parenteral drug delivery, will discuss how understanding the strengths and weaknesses of current drug delivery approaches can inform accelerated growth.

He argues that this evolution can occur only by increasing the number of trials testing diverse and bold ideas, as well as accepting errors and learning from them. Park is also the president of Akina, Inc., which specializes in drug delivery technologies and specialty polymers, and editor-in-chief of the Journal of Controlled Release.

The Hoffman Lecture honors UW Bioengineering’s Allan Hoffman, now in his 58th year of active research. He joined the UW faculty in 1970, when he began to synthesize polymers and hydrogels with special physical and biomedical properties. He has pioneered the applications of temperature- and pH-responsive intelligent polymers and hydrogels in drug delivery and diagnostic assays and continues to be an international “ambassador for biomaterials.”

For more information, contact Shirley Nollette at 206-685-2002 or nolletts@uw.edu.